As discussed in
Chapter 2, many patients and researchers are critical of the term “chronic fatigue syndrome,” which is the name most commonly ascribed to this disease in the United States (but not in other parts of the world). Patients in particular find this term stigmatizing and trivializing, and there is evidence to support these perspectives. The way an illness is labeled affects the illness experience (
Wojcik et al., 2011). Labels convey meanings that affect patients' perception of their illness as well as the reactions of others, including medical personnel, family members, and colleagues (
Jason and Richman, 2008;
Jason et al., 2002b;
Wojcik et al., 2011). As noted in
Chapter 2, patients have reported that many clinicians are dismissive, making such comments as “I am fatigued all the time, too.” Perceptions of a patient by others are important because they have been shown to affect the course of a disorder and may be associated with different outcomes (
Wojcik et al., 2011).
In addition to the personal experiences presented in
Chapter 2, several investigators have examined the attitudes and beliefs elicited by different diagnostic labels for ME/CFS. Among medical students, the term “myalgic encephalomyelitis” was more likely to be classified as a disease than the term “chronic fatigue syndrome” (
Erueti et al., 2012). Among medical trainees and college students, the term “myalgic encephalomyelitis” was “more likely to prompt beliefs in a physiological cause for the illness” than the term “chronic fatigue syndrome” (
Jason et al., 2002b,
2004a, p. 223).
Conclusion: The committee agrees that the term “chronic fatigue syndrome” often results in stigmatization and trivialization and should no longer be used as the name of this illness.
https://www.ncbi.nlm.nih.gov/books/NBK284898/#sec_058